Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 15

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 15
---
the “Fisher Employment Agreement”),
and pursuant to Dr. Fisher’s Separation Agreement with the Company, effective as of November 27, 2023 (the “Separation Agreement”),
the Company will provide Dr. Fisher with (1) cash severance equivalent to twelve months of Dr. Fisher’s base salary in effect as
of the Separation Date, subject to standard payroll deductions and withholdings, payable over the Company’s regular payroll schedule
over the twelve months following the Separation Date; (2) the accelerated vesting on fifty percent (50%) of the outstanding and unvested
equity awards held by Dr. Fisher that were subject to time-based vesting as of the Separation Date, which were deemed fully vested and
exercisable as of the Separation Date; and (3) reimbursement of COBRA healthcare premium costs for the same level of coverage Dr. Fisher
had during his employment with the Company, until the earliest of (i) twelve months from November 27, 2023, (ii) the date Dr. Fisher becomes
eligible for substantially equivalent healthcare coverage through another source, or (iii) the expiration of Dr. Fisher’s eligibility
for the continuation coverage. Further, and pursuant to the Separation Agreement, Dr. Fisher provided the Company with a general release
of all claims, effective November 27, 2023.

Employment Arrangements

We currently have written employment agreements with
our executive officers. For information about our employment agreements with our named executive officers, refer to “Executive and
Director Compensation — Employment Contracts.”

Equity Awards Granted to Executive Officers and Directors

We have granted stock options and RSUs to our executive
officers and directors. For information about our grants of stock option awards and RSUs to our named executive officers and our directors,
refer to “Executive and Director Compensation — Outstanding Equity Awards at 2024 Fiscal Year-End,” “Executive
and Director Compensation — Director Compensation for 2024 Fiscal Year” and “Executive and Director Compensation —
Non-Employee Director Compensation Policy.”

Indemnification Agreements

We have entered into and intend to continue to enter into indemnification agreements with each of our directors and our officers. The indemnification agreements, our Articles of Incorporation, as amended, and our Amended and Restated Bylaws require us to indemnify our directors and officers to the fullest extent permitted by Nevada law.

Policies and Procedures for Transactions with Related Persons

We maintain a written policy that